OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 15, 2020
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
October 02, 2020
The case for migrating from a paper-based quality management system to a digital platform is presented.
European pharma companies may have a vested interest in the outcome of the US elections.
September 02, 2020
AstraZeneca has potentially taken poll position in the race to develop a novel coronavirus vaccine, but will AZD1222 be ready in 2020?
August 02, 2020
COVID-19 has brought to light the issues of European manufacturing capabilities, leading industry to question whether it is now time to reinvest in domestic medicines supply.
COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.
July 02, 2020
COVID-19 vaccines are being developed rapidly, giving rise to a reinvigoration of the sector.
As Brexit talks intensify, bio/pharma companies from both the UK and EU need to consider and aim to prepare for all scenarios.
June 02, 2020
Pharma’s reputation is being boosted in light of the current COVID-19 pandemic efforts.
May 27, 2020
A network-based supply chain approach has the potential to improve resilience and performance.